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Abstract 
We report on the variable venom composition of a population of the Caucasus viper (Vipera 
kaznakovi) in Northeastern Turkey. We applied a combination of venom gland transcriptomics, 
and de-complexing bottom-up and top-down venomics. In contrast to sole bottom-up venomics 
approaches and gel or chromatography based venom comparison, our combined approach 
enables a faster and more detailed comparison of venom proteomes from multiple individuals. 
In total, we identified peptides and proteins from 15 toxin families, including snake venom 
metalloproteinases (svMP; 37.8%), phospholipases A2 (PLA2; 19.0%), snake venom serine 
proteinases (svSP; 11.5%), C-type lectins (CTL; 6.9%) and cysteine-rich secretory proteins 
(CRISP; 5.0%), in addition to several low abundant toxin families. Furthermore, we identified 
intraspecies variations of the venom composition of V. kaznakovi, and find these were mainly 
driven by the age of the animals, with lower svSP abundance detected in juveniles. On the 
proteoform level, several small molecular weight toxins between 5 and 8 kDa in size, as well as 
PLA2s, drove the differences observed between juvenile and adult individuals. This study 
provides novel insights into the venom variability of V. kaznakovi and highlights the utility of 
intact mass profiling for fast and detailed venom comparisons of snake.  
 
 
Biological Significance 
Population level and ontogenetic venom variation (e.g. diet, habitat, sex or age) can result in a loss of 
antivenom efficacy against snakebites from wide ranging snake populations. The current state of the 
art for the analysis of snake venoms are de-complexing bottom-up proteomics approaches. While 
useful, these have the significant drawback of being time-consuming and following costly protocols, 
and consequently are often applied to pooled venom samples. To overcome these shortcomings and to 
enable rapid and detailed profiling of large numbers of individual venom samples, we integrated an 
intact protein analysis workflow into a transcriptomics-guided bottom-up approach. The application 
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of this workflow to snake individuals of a local population of V. kaznakovi revealed intraspecies 
variations in venom composition, which are primarily explained by the age of the animals, and 
highlighted svSP abundance to be one of the molecular drivers for the compositional differences 
observed.  
 
Highlights 
 First venomic analysis of a local population of the Caucasus viper (Vipera kaznakovi). 
 The venom gland transcriptome of V. kaznakovi identified 46 toxin genes relating to 15 venom 
toxin families. 
 Bottom-up venomics revealed the identification of 25 proteins covering 7 toxin families mainly 
dominated by snake venom metalloproteinases (svMP). 
 Population venomics by top-down mass profiling revealed ontogenetic shifts between juvenile 
and adult snakes. 
 
Keywords: Viperidae, Snake, Middle East, Toxin, Caucasus viper, Vipera kaznakovi, Snake 
Venomics, Transcriptomics, Top-down Venomics, Population Venomics, Venom, Toxin 
 
 
1. Introduction 
Venomics is considered an integrative approach, that can combine proteomics, transcriptomics and/or 
genomics to study venoms [1]. Although the term was initially used to describe the mass 
spectrometry-based proteomic characterization of venoms [2,3], genomic [4,5] or more commonly 
venom gland transcriptomic sequencing [6–14] have also been used to characterize venom 
compositions. These molecular approaches provide an overview of venom composition by 
characterizing the nucleotide sequences of venom toxin-encoding genes (among others) and, in the 
case of transcriptomics, also provide an estimation of their relative expression in the venom gland. 
Furthermore, (translated) protein sequence databases are crucial for the robust annotation of tandem 
mass spectra from proteomic analyses in peptide/protein spectrum matching (PrSM). A bibliographic 
search to the keyword “Snake venomics” in PubMed identified 147 hits between 2004 and 2018, 
including a rapid expansion in the application of venomics approaches in more recent years. 
Initial proteomic analyses of snake venoms included the combination of multidimensional separation 
techniques (chromatographic and gel electrophoresis), N-terminal Edman degradation, and de novo 
sequencing by tandem mass spectrometry of tryptic peptides generated by in-gel digestion of SDS-
PAGE bands [2,15]. Since these initial studies, the proteomic characterization of snake venoms has 
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become more comprehensive due to technical advances in mass spectrometry and next generation 
nucleotide sequencing. Several complementary strategies were developed to unveil the venom 
proteomes of more than 100 snake species [16]. Most of these studies applied the so called ‘bottom-
up’ proteomic approaches, whereby intact proteins are typically digested with trypsin before tandem 
mass spectrometry analysis. Many workflows perform venom decomplexation prior to digestion, 
either by liquid chromatography (LC) or gel electrophoresis, or a combination of both [17]. The 
direct, in-solution digestion, or so called ‘shotgun proteomics’, allows for a fast qualitative overview, 
but suffers from a less quantitative breakdown of snake venom composition [17,18]. For example, in 
shotgun experiments, the problem of protein inference often does not permit the differentiation of the 
numerous toxin isoforms present in venom [19]. Thus, chromatographic or electrophoretic separation 
of venom samples greatly aids in differentiating between toxin isoforms (encoded by paralogs). In 
addition, decomplexing prior to trypsin digestion often does not allow for the clear identification of 
differential post-translational modified variants, so-called proteoforms [20]. 
To circumvent these limitations, a logical solution would be the of the digestion step and the 
application of direct analysis of intact proteins by tandem mass spectrometry, so called top-down 
proteomics. Recently top-down protein analysis has been applied alone, or in combination with other 
venomics approaches, to study the venoms of the King cobra (Ophiophagus hannah) [21,22], the 
entire genus of mambas (Dendroaspis spp.) [23,24], the brown tree snake (Boiga irregularis) [6], the 
Okinawa habu pit viper (Protobothrops flavoviridis) [25], and several viper species from Turkey [26–
28]. In the case of viperid species, top-down analysis typically only results in partial characterization 
of the venom, as a number of the main toxin components, such as high molecular weight snake venom 
metalloproteinases (svMPs) (>30 kDa), are challenging to efficiently ionize by denaturing 
electrospray ionization (ESI) and might only provide few observable fragments in tandem MS [29]. A 
possible way to overcome difficulties in terms of ionization of high molecular weight proteins is the 
application of native ESI, as described by Melani et al. [22]. However native top-down mass 
spectrometry typically requires a special type of mass spectrometer with extended mass range and 
more extensive sample preparation, which makes this type of analysis more technically challenging.  
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In the majority of the aforementioned studies, the top-down workflows were performed with a front-
end LC-based sample decomplexation. This allows for the generation of MS1 mass profiles (XICs) of 
intact proteoforms. Typically, the MS1 information is accompanied by tandem MS (MS2) information 
acquired in data-dependent acquisition (DDA) mode. The MS2 fragment spectra are than matched to a 
translated transcriptome/genome database in order to identify the proteins. In the case that there are 
not enough MS2 fragment peaks of a particular proteoform, the intact molecular mass can still enable 
identification, especially if the intact mass can be associated to masses observed in complementary 
experiments, such as retention time, mass range of SDS-PAGE and/or bottom-up protein IDs of 
decomplexed bottom-up venomics [26]. The additional information gained through exact intact 
protein masses can be particularly informative to differentiate between isoforms or proteoforms. As 
several studies have shown correlations between different ecological, geographical, genetic and/or 
developmental factors and the venom proteome, e.g. different diets [30–33], regional separation of 
populations [10,34–36], sex [37–39] or age [40–43] it would be ideal to characterize venom 
composition from a representative cohort of individual animals. However, due to the time consuming 
nature and expensive costs associated with de-complexing bottom-up venom analysis, most venom 
compositions reported so far [16], were analyzed from a single pool of venom that was sourced from 
different numbers of individuals. In top-down approaches on the other hand, the simple sample 
preparation, high sensitivity and fast analysis time allows for a rapid and cheaper comparison of 
venom composition, and thus seems well suited for large scale quantitative comparisons [44–46] of 
snake venoms. In addition to providing a better biological understanding of the toxins present in 
venom [47], and the evolutionary processes underpinning population level venom variations [48], 
population wide venom analyses would provide important information to better understand regional 
and intraspecific variations in the venom composition of medically important snake species, which 
has considerable relevance for the development and clinical utility of antivenom treatment for 
snakebite [49,50].  
In this study, we explored the utility of top-down intact mass profiling to identify intraspecific venom 
variation by applying it to a local population of the medical relevant Caucasus viper (Vipera 
kaznakovi). The Caucasus viper is a subtropical, medium-sized, viper species with a wide distribution 
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range from the Caucasus Black Sea coastal provinces of Artvin and Rize in northeastern Turkey 
(Figure 1), through Georgia to Russia. A distinctive characteristic of this species is the black 
coloration with elements of an orange to red zigzag-looking on the dorsal side of the body (Figure 1). 
This species feeds predominately on small vertebrates (mice, lizards etc.) and insects [51].  
In a previous shotgun proteomics study of this species, Kovalchuk and coworkers described the 
venom of V. kaznakovi (Krasnodar Territory, near Adler, Russia) to be composed of phospholipase A2 
(PLA2, 19.0%), snake venom metalloproteases (svMP, 16.2%), snake venom serine proteases (svSP, 
10.8%), Cysteine-rich secretory proteins (CRISP, 9.7%), C-type lectins (CTL, 12.5%), L-amino acid 
oxidase (LAAO, 4.0%), vascular endothelial growth factor (VEGF, 4.0%), disintegrins (Dis, 0.5%), 
phospholipase B (PLB, 0.3%), nerve growth factors (NGF, 0.14%), as well as a number of other 
venom proteins of lower abundance [52]. Here, we used a combination of venom gland 
transcriptomics, decomplexing bottom-up proteomics and comparative top-down proteomics to 
provide a more detailed characterization of the venom composition of V. kaznakovi, and to gain first 
insights into intraspecies variation of its venom composition. Furthermore, our findings highlight the 
potential of intact protein mass profiling for future population level studies of viperid venoms. 
 
2. Material & Methods 
2.1. Sampling 
Venom samples of V. kaznakovi were collected from 6 adult (2 female, 4 male) and 3 juvenile 
specimens (unknown sex). All specimens were captured in late June 2015 in their natural habitat and 
released back into their natural environment after venom extraction. The V. kaznakovi individuals 
were collected in Artvin province in Turkey near the Georgian border, with 6 individuals sampled 
from Hopa district, 2 individuals from Borçka district and 1 specimen in the Arhavi district. An 
additional female individual found in Borçka district was collected for venom gland dissection for 
transcriptomic analysis. Ethical permission (Ege University Animal Experiments Ethics Committee, 
2013#049) and special permission (2015#124662) for the sampling of wild-caught V. kaznakovi were 
received from the Republic of Turkey, Ministry of Forestry and Water Affairs. Geographic 
coordinates for all V. kaznakovi individuals are provided in supplemental table 2. 
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2.2. Sample storage and preparation 
Crude V. kaznakovi venom was extracted by using a parafilm-covered laboratory beaker without 
exerting pressure on the venom glands. Venom samples were centrifuged at 2000 × g for 10 min at 
4 °C to remove cell debris. Supernatants were immediately frozen at −80 °C, lyophilized, and the 
samples stored at 4 °C until use. 
 
2.3. Determination of lethal dose (LD50) 
The lethal potency (LD50) of pooled V. kaznakovi venom to mice (mg/kg) was determined by an up-
and down method as recommended by the Organization for Economic Cooperation and Development 
(OECD) guidelines (Test No. 425) [53,54]. Groups of five Swiss albino mice (n = 15; age, 8 to 10 
weeks; female 8 and male 7 individuals) were used per venom dose. Various venom concentrations 
(5, 2 and 1 mg/kg, milligrams of protein per kg calculated from dry weight venom by Bradford assay) 
were diluted in ultrapure water to a final volume of 100 µL and injected by the intraperitoneal (IP) 
route. Control mice (n = 5; female 2 and male 3 individuals) received a single IP injection of sterile 
saline (0.9%, 100 µL). All assays and procedures involving animals strictly followed the ethical 
principles in animal research adopted by the Swiss Academy of Medical Sciences [55]. Additionally, 
they were approved by a local ethics committee (2013#049). Mortality was recorded 24 h after 
injection, and the median lethal dose was determined by a nonlinear regression fitting procedure in 
GraphPad Prism 5 (Version 5.01, Inc., San Diego, CA, USA). 
 
2.4. RNA isolation and purification 
Venom glands were dissected from a wild caught adult female specimen of V. kaznakovi in Kanlıdere, 
Hopa district (Artvin province) and processed as previously described [9,24]. Briefly, immediately 
following euthanasia, venom glands were dissected and were immediately flash frozen in liquid 
nitrogen and stored cryogenically prior to RNA extraction. Venom glands were next homogenized 
under liquid nitrogen and total RNA extracted using a TRIzol Plus RNA purification kit (Invitrogen), 
DNAse treated with the PureLink DNase set (Invitrogen) and poly(A) selected using the Dynabeads 
mRNA DIRECT purification kit (Life Technologies), as previously detailed [9,24]. 
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2.5. RNA sequencing, assembly and annotation 
RNA-Seq was performed as described in [9,24]. The RNA-Seq library was prepared from 50 ng of 
enriched RNA material using the ScriptSeq v2 RNA-Seq Library Preparation Kit (epicenter, Madison, 
WI, USA), following 12 cycles of amplification. The resulting sequencing library was purified using 
AMPure XP beads (Agencourt, Brea, CA, USA), quantified using the Qubit dsDNA HS Assay Kit 
(Life Technologies), before the size distribution was assessed using a Bioanalyser (Agilent). The 
library was then multiplexed and sequenced (alongside other sequencing libraries not reported in this 
study) on a single lane of an Illumina MiSeq (250 bp paired end sequencing), housed at the Centre for 
Genomic Research, Liverpool, UK. The V. kaznakovi library amounted to 1/6th of the total sequencing 
lane. The ensuing read data was quality processed by (i) removing the presence of any adapter 
sequences using Cutadapt (https://code.google.com/p/cutadapt/) and (ii) trimming low quality bases 
using Sickle (https://github.com/najoshi/sickle). Reads were trimmed if bases at the 3' end matched 
the adapter sequence for 3 bp or more, and further trimmed with a minimum window quality score of 
20. After trimming, reads shorter than 10 bp were removed. 
For sequence assembly we used VTBuilder, a de novo transcriptome assembly program previously 
designed for discriminating between multiple related toxin isoforms during the construction of snake 
venom gland transcriptomes [56], which has previously been utilized for integrating venom toxin 
gene data with venom proteomic data [9,24]. Paired-end read data was entered into VTBuilder and 
executed with the following parameters: min. input read length 150 bp; min. output transcript length 
300 bp; min. isoform similarity 96%. Assembled contigs were annotated with BLAST2GO Pro v3 
[57] using the blastx-fast algorithm with a significance threshold of 1e-5, to provide BLAST 
annotations (max 20 hits) against NCBI’s non redundant (NR) protein database (41 volumes; Nov 
2015) followed by mapping to gene ontology terms, and Interpro domain annotation using default 
parameters. Following generic annotation, venom toxins were initially identified based on their 
BLAST similarity to sequences previously identified in the literature or in molecular databases as 
snake venom toxins, and then manually curated for validation. 
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2.6. Venom proteomics (bottom-up) 
The crude venom (1 mg) was dissolved to a final concentration of 10 mg/ml in aqueous 3% (v/v) 
acetonitrile (ACN) with 1% (v/v) formic acid (FA) and centrifuged at 16,000 g for 5 min to spin down 
insoluble content. The supernatant was loaded onto reversed-phase HPLC with a Supelco Discovery 
BIO wide Pore C18-3 column (4.6 x 150 mm, 3 µm particle size) using an Agilent 1260 Low Pressure 
Gradient System (Agilent, Waldbronn, Germany). The column was operated with a flow rate of 
1 mL/min and run with ultrapure water (solution A) and ACN (solution B), both including 0.1% (v/v) 
FA. A standard separation gradient was used with solution A and solution B, starting isocratically (5% 
B) for 5 min, followed by linear gradients of 5-40% B for 95 min and 40-70% for 20 min, then 70% B 
for 10 min, and finally re-equilibration at 5% B for 10 min. Peak detection was performed at λ = 214 
nm using a diode array detector (DAD). After the chromatographic separation of the crude venom, the 
collected and vacuum-dried peak fractions were submitted to SDS-PAGE gel electrophoresis (12% 
polyacrylamide). Subsequently, the coomassie-stained bands were excised, and submitted to in-gel 
trypsin digestion, reduced with fresh dithiothreitol (100 mM DTT in 100 mM ammonium 
hydrogencarbonate, pH 8.3, for 30 min at 56 °C) and alkylated with iodoacetamide (55 mM IAC in 
100 mM ammonium hydrogencarbonate, pH 8.3, for 30 min at 25 °C in the dark). The resulting 
peptides were then extracted with 100 µL aqueous 30% (v/v) ACN with 5% (v/v) FA for 15 min at 
37 °C. The supernatant was vacuum-dried (Thermo speedvac, Bremen, Germany), redissolved in 
20 µL aqueous 3% (v/v) ACN with 1% (v/v) FA and submitted to LC-MS/MS analysis. 
The bottom-up analyses were performed with an Orbitrap XL mass spectrometer (Thermo, Bremen, 
Germany) via an Agilent 1260 HPLC system (Agilent Technologies, Waldbronn, Germany) using a 
reversed-phase Grace Vydac 218MSC18 (2.1 x 150 mm, 5 µm particle size) column. The pre-
chromatographic separation was performed with the following settings: after an isocratic equilibration 
(5% B) for 1 min, the peptides were eluted with a linear gradient of 5-40% B for 10 min, 40-99% B in 
3 min, held at 99% B for 3 min and re-equilibrated in 5% B for 3 min. 
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2.7. Population level venom profiling (top-down) 
The top-down MS analysis was performed by dissolving the crude venoms in ultrapure water 
containing formic acid (FA, 1%) to a final concentration of 10 mg/mL, and centrifuged at 20,000 x g 
for 5 min.  Aliquots of 10 μL dissolved venom samples were submitted to reverse-phase (RP) HPLC-
high-resolution (HR)-MS analyses. RP-HPLC-HR-MS experiments were performed on an Agilent 
1260 HPLC system (Agilent, Waldbronn, Germany) coupled to an Orbitrap LTQ XL mass 
spectrometer (Thermo, Bremen, Germany). RP-HPLC separation was performed on a Supelco 
Discovery Biowide C18 column (300 Å pore size, 2 × 150 mm column size, 3 μm particle size). The 
flow rate was set to 0.3 mL/min and the column was eluted with a gradient of 0.1% FA in water 
(solution A) and 0.1% FA in ACN (solution B): 5% B for 5 min, followed by 5–40% B for 95 min, 
and 40–70% for 20 min. Finally, the gradient was held isocratic with 70% B for 10 min and re-
equilibrated at 5% B for 10 min. ESI settings were: 11 L/min sheath gas; 35 L/min auxiliary gas; 
spray voltage, 4.8 kV; capillary voltage, 63 V; tube lens voltage, 135 V; and capillary temperature, 
330 °C. MS/MS spectra were obtained in data-dependent acquisition (DDA) mode. FTMS 
measurements were performed with 1 μ scans and 1000 ms maximal fill time. AGC targets were set to 
106 for full scans and to 3 × 105 for MS/MS scans, and the survey scan as well as both data dependent 
MS/MS scans were performed with a mass resolution (R) of 100,000 (at m/z 400). For MS/MS the 
two most abundant ions of the survey scan with known charge were selected. Normalized CID energy 
was set to 30% for the first, and 35% for the second, MS/MS event of each duty cycle. The default 
charge state was set to z = 6, and the activation time to 30 ms. Additional HCD experiments were 
performed with 35% normalized collision energy, 30 ms activation time and z = 5 default charge 
state. The mass window for precursor ion selection was set to 2 or 6 m/z. A window of 3 m/z was set 
for dynamic exclusion of up to 50 precursor ions with a repeat of 1 within 10 s for the next 20 s.  
 
2.8. Bioinformatic analysis 
The LC-MS/MS data files (.raw) obtained from the in-gel digestion were converted to mascot generic 
format (.mgf) files via MSConvert GUI of the ProteoWizard package 
(http://proteowizard.sourceforge.net; version 3.0.10328) and annotated by DeNovo GUI [58] 
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(version 1.14.5) with a mass accuracy of 10 ppm for precursor mass and 0.2 m/z for fragment peaks. 
A fixed modification carbamidomethyl cysteine (C +57.02 Da) was selected. Resulting sequence tags 
were examined manually and searched against the non-redundant Viperidae protein database (taxid: 
8689) using the basic local alignment search tool (BLAST) [59]. 
For peptide spectrum matching, the SearchGUI software tool was used with XTandem! as the search 
engine [60]. The MS2 spectra were searched against the non-redundant Viperidae protein NCBI 
(taxid: 8689, 3rd Nov 2017, 1727 sequences), our in-house Vipera kaznakovi toxin sequence database 
(translated from our venom gland transcriptomic analyses; 46 toxin sequences) and a set of proteins 
found as common contaminants (CRAP, 116 sequences), containing in total 1,889 sequences. Mass 
accuracy was set to 10 ppm for the precursor mass and 0.2 m/z for the MS2 level. The alkylation of 
Cys was set as a fixed modification and acetylation of the N-terminus, of Lys, as well as oxidation of 
Met, were allowed as variable modifications. A false discovery rate (FDR) was estimated through a 
target-decoy approach and a cut-off of 1% was applied. All PSMs were validated manually and at 
least two PSMs were required for a protein ID to be considered.  
For the top-down data analysis, the .raw data were converted to .mzXML files using MSconvert of the 
ProteoWizard package (http://proteowizard.sourceforge.net; version 3.0.10328), and multiple charged 
spectra were deconvoluted using the XTRACT algorithm of the Xcalibur Qual Browser version 2.2 
(Thermo, Bremen, Germany). For isotopically unresolved spectra, charge distribution deconvolution 
was performed using the software tool magic transformer (MagTran). 
 
2.9. Multivariable statistics 
Principal component analysis (PCoA), using the relative percentages of the major toxin families as 
well as different proteoforms as variables, was applied to investigate determinants of compositional 
variation among venoms. PCoA was performed in R (R Foundation for Statistical Computing, 2016) 
with the extension Graphic Package rgl, available from https://www.R-Project.org. 
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2.10. Data sharing 
Mass spectrometry proteomics data (.mgf, .raw and results files and search database) have been 
deposited to ProteomeXchange [61] with the ID PXD010857 via the MassIVE partner repository 
under project name “Venom proteomics of Vipera kaznakovi” and massive ID MSV000082845. Raw 
sequencing reads and the assembled contigs generated for the venom gland transcriptome (.fastq and 
.fasta, respectively) have been deposited in the NCBI sequence read archive (SRA) under accession 
SRR8198764 and linked to the BioProject identifier PRJNA505487.  
 
3. Results and Discussion 
3.1. Field work and venom toxicity 
During our fieldwork in June 2015 we collected nine V. kaznakovi individuals (6 adults and 3 
juveniles) in their natural habitat, and extracted their venom before releasing them back into their 
natural environment. The different V. kaznakovi individuals were found in the Hopa (6 spec.), Borçka 
(2 spec.) and Arhavi (1 spec.) districts of Artvin province (Figure 1). The LD50 mean values of venom 
pooled from all collected V. kaznakovi individuals was assessed by the intraperitoneal (IP) route using 
a random sample survey of five Swiss albino mice for three venom dose (5, 2 and 1 mg/kg), which is 
summarized in supplemental table 1. The LD50 value obtained for the pooled V. kaznakovi venom was 
calculated as ~2.6 mg/kg (2.1-3.4 mg/kg) and can be categorized to have slightly weaker toxicity in 
this model, when compared to other related viper species (0.9-1.99 mg/kg) [62–65]. 
 
3.2. Venom gland transcriptomics 
The V. kaznakovi venom gland transcriptome resulted in 1,742 assembled contigs, of which 46 
exhibited gene annotations relating to 15 venom toxin families previously described in the literature 
(Figure 2). The majority of these contigs (33) encode genes expressing toxin isoforms relating to four 
multi-locus gene families, namely the svMPs, CTLs, svSPs and PLA2s (Figure 2). Moreover, these 
four toxin families also exhibited the highest expression levels of the toxin families identified; in 
combination accounting for >78% of all toxin expressions (Figure 2). These findings are consistent 
with many prior studies of viperid venom gland transcriptomes [10,12,49,66,67]. 
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The svMPs were the most abundantly expressed of the toxin families detected, accounting for 33.4% 
of the total toxin expression, and were encoded by 17 contigs (Figure 2). However, these contig 
numbers are likely to be an overestimation of the total number of expressed svMP genes found in the 
V. kaznakovi venom gland, as six of these contigs were incomplete and non-overlapping in terms of 
their nucleotide sequence, and therefore likely reflect a degree of low transcriptome coverage and/or 
under-assembly. Of those contigs that we were able to identify to svMP class level (e.g. P-I, P-II or P-
III [68,69]), ten exhibited structural domains unique to P-III svMPs, one to P-II svMPs and one to a 
short coding disintegrin. The svMP contig that exhibited the highest expression level encoded for the 
sole P-II svMP (5.1% of all venom toxins), whereas the short coding disintegrin, which exhibited 98% 
identity to the platelet aggregation inhibitor lebein-1-alpha from Macrovipera lebetina [70], was more 
moderately expressed (2.1%). Interestingly, we found no evidence for the representation of the P-I 
class of svMPs in the V. kaznakovi venom gland transcriptome. 
The CTLs were the next most abundant toxin family, with six contigs representing 27.5% of all toxin 
gene expression (Figure 2). One of these CTLs, which exhibits closest similarity to snaclec-7 from 
Vipera ammodtyes venom (GenBank: APB93444.1), was by far the most abundantly expressed toxin 
identified in the venom gland transcriptome (15.4% of all toxins) (Figure 2). We identified lower 
expression levels for the multi-locus svSP and PLA2 toxin families, which accounted for 9.2% and 
8.1% of the total toxins, expressed in the venom gland transcriptome respectively, and were encoded 
by seven and three contigs (Figure 2). Of the remaining toxin families identified, only two exhibited 
expression levels >3% of the total toxin expression; CRISPs were encoded by two contigs amounting 
to 5.4% of total toxin expression, and LAAO by a single contig representing 4.2% (Figure 2). The 
remaining nine, lowly expressed, toxin families identified in the venom gland transcriptome are 
displayed in Figure 2, and combined amounted to 12.1% of total toxin expression.  
 
3.3 Venom proteomics of pooled venom 
To broadly characterize the venom composition of V. kaznakovi, we performed bottom-up analysis of 
pooled venom by reversed phase-HPLC separation (Figure 3A) and direct online intact mass analysis 
by ESI-HR-MS (Figure 3B). The prominent bands of the subsequent separation by SDS-PAGE 
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(Figure 3C) were excised followed by trypsin in-gel digestion and LC-MS/MS analysis. During the 
first analysis we did not have a species-specific transcriptome database available, hence the spectra 
were analyzed by de novo sequencing. The resulting sequence tags were searched against the NCBI 
non-redundant viperid protein database using BLAST [59]. The 57 sequence tags resulted in the 
identification of 25 proteins covering seven toxin families (Table 1), namely svMP, PLA2, svSP, 
CTL, CRISP, VEGF and LAAO.  
De novo sequencing of MS/MS spectra of native small peptides (peaks 1-9) resulted in four additional 
sequence tags and the identification of a svMP inhibitor (svMP-i) and two bradykinin potentiating 
peptides (BPP). When we obtained the assembled transcriptome data, we re-analyzed the MS/MS data 
from the tryptic peptides by peptide spectrum matching (PSM) using the translated protein sequences 
of the transcriptome as well as the NCBI Viperidae protein database. PSM resulted in 114 peptide 
matches in total, which doubled the number of annotated spectra in comparison to the de novo 
annotation. The analysis revealed the same seven major toxin families as identified by the tryptic de 
novo tags, but showed 29 identified proteins (compared to 25 by the prior approach) and thus a 
modest improvement. Not surprisingly, most of the peptide matches were from the transcriptome 
derived sequences, with only six protein IDs sourced from other viperid sequences in the NCBI 
database. Relative quantification through integration of the UV-HPLC peaks and densitometric 
analysis of the SDS-PAGE gels revealed that the most abundant toxin families were svMP (37.7%), 
followed by PLA2 (19.0%), svSP (9.6%), LAAO (7.1%), CTL (6.9%), CRISP (5.0%), and VEGF 
(0.3%). In the small molecular mass range (< 2kDa), SVMP-i represented 12.6%, BPP 2.0%, and 
unknown peptides 4.0% of the overall venom composition (Figure 3D).  
When comparing the abundance of venom toxins (Figure 3D) with transcriptomic predictions of 
expression levels (Figure 2A), we observed an overall positive correlation, but also noted some major 
differences, particularly relating to the CTLs: transcriptomic expression levels showed CTLs to be the 
second most abundant toxin family (27.5% of all toxins) while proteomic analysis showed a much 
lower abundance (6.9%). Interestingly, some of the molecular masses observed for CTLs (~20 kDa) 
during SDS-PAGE did not correspond to the expected molecular mass derived from the transcriptome 
sequences. As reported in other studies, we assume that some of the observed CTLs are hetero-dimers 
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[71]. SvMPs showed highly consistent profiles, as both the most abundantly expressed (33.4%) and 
translated (32.7%) toxin family. Similarly, the svSPs (9.2%) and CRISPs (5.4%) exhibited 
transcription levels highly comparable to their relative protein abundance in venom (9.6% and 
5.02%). A lower transcription level was shown for PLA2 (8.1%) in contrast to the two times higher 
protein level (19.0%). As anticipated, with the exception of VEGF (2.0% T; 0.4% P) and svMP-i 
(1.7%; 12.6%) as part of the peptidic content, other lowly expressed ‘toxin’ families could not be 
assigned on the proteomic level.  
The observed discrepancies in proteomic abundance and transcriptomic expression (e.g. CTLs and 
PLA2s) could be influenced by many factors, e.g. post-genomic factors acting on toxin genes [49], 
such as the regulation of expression patterns by MicroRNAs (miRNA) [7,72], degradation processes 
[73], systematic or stochastic variations [74] or technical limitations in our experimental approaches, 
including the lower sensitivity of the proteomics workflow. Perhaps most importantly, we compared 
the toxin transcription level of a single individual (adult female) to a pooled venom protein sample 
(n=9), and thus, while it is possible that these differences are predominately due to the above 
mentioned regulatory processes, it seems likely that intra-specific venom variations may also 
influence our findings. Due to sampling/ethical restrictions relating to the sacrifice of multiple 
individuals, we were unable to sequence venom gland transcriptomes of additional specimens of V. 
kaznakovi to investigate this further. 
The previous proteomic characterization of V. kaznakovi venom by Kovalchuk and coworkers was 
performed by in-solution trypsin proteolysis followed by nanoLC-MS/MS [52]. The PSM against a 
full NCBI Serpentes database identified 116 proteins from 14 typical snake venom protein families. 
The semi-quantitative venom composition showed PLA2 (41.0%) as the most abundant component, 
followed by svMPs (16.2%), CTL (12.5%), svSP (10.8%), CRISP (9.7%), LAAO (4.0%), VEGF 
(4.0%) and other lowly abundant proteins (< 1%) [52]. The main difference between these findings 
and those described herein, are the considerably higher levels of PLA2 and the lower abundance of 
svMPs (~ 4 fold difference for both protein families). The reasons for the additional detection of 
lowly abundant proteins could be of technical nature, as the nanoLC-MS/MS and mass spectrometer 
used in the previous study is typically more sensitive than the LC-MS/MS setup we applied. 
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Differences in protein abundance could also be the result of the different quantification methods 
applied (UV abundance vs. summed peptide abundance [52]), but the observed variations could also 
be biological in nature, i.e. the result of intra-specific venom variation, as the animals were collected 
in distinct geographic regions (Krasnodar Territory, Russia [51], with a distance of ~ 400 km to our 
collection site in Turkey). However, as in most other venom proteomics studies, Kovalchuk et al. 
determined toxin composition using a pooled venom sample (15 individuals [52]), which has the 
potential to offset variation among individuals. Therefore, in order to robustly assess the extent of 
intra-specific (e.g. population level) venom variation in V. kaznakovi, analysis of a representative 
group of individuals is necessary. 
 
3.4 Population level venom profiling 
It is understandable that many venom proteomic studies were undertaken using pooled samples, due 
to the associated costs and analysis time of decomplexing bottom-up venomics. For example, herein 
we fractionated pooled venom from V. kaznakovi into 25 fractions and further separated the protein 
containing fractions (MW >5kDa) by SDS-PAGE. This multidimensional separation resulted in 25 
digested peptide samples which were analyzed by LC-MS/MS, requiring ~ 10 h MS run time 
(25 min/sample), and an estimated ~ US$1250 costs (US$50/sample). Multiplying this effort and cost 
by numerous venom samples from individuals would of course make such a study comparatively 
expensive. Hence, many previous studies investigating venom variability within a species have used 
pooled venom for in-depth proteomic analysis, and then illuminated individual variability by the 
comparison of HPLC chromatograms and/or SDS-PAGE images [50,75–77]. However, such an 
approach allows at best a comparison at the protein family level (if protein families are clearly 
separated by HPLC or SDS-PAGE). As an alternative, top-down or shotgun proteomics would 
facilitate differential comparisons on the protein, or potentially proteoform, level, by performing a 
single LC-MS/MS run per individual. Taking into account the longer LC-MS run-times (120 min/run) 
for shotgun or top-down analysis and costs than can be estimated to be ~ US$200 per venom sample – 
the analysis would be significantly cheaper and faster. However, shotgun approaches are likely to 
suffer from the aforementioned issues with protein inference, while top-down approaches have the 
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drawback of not resolving high molecular mass proteins. This is particularly the case if the 
identification and comparison of proteins are based on Protein Spectrum Matching (PrSM), as high 
molecular weight toxins may not result in isotope resolved peaks and sufficient precursor signal, and 
thus are unlikely to provide sufficient fragment ions. However, a comparison by MS1 mass profiling 
only [78] would eliminate the problem of insufficient MS/MS fragments and isotope resolution, as 
spectra can be easily deconvoluted based on their charge state distribution. Such an approach could be 
particularly interesting for laboratories that are equipped with low resolution mass spectrometers. 
In order to explore the potential of venom comparison by top-down mass profiling, we analyzed the 
venoms of nine V. kaznakovi individuals by LC-MS using the same chromatographic method as for 
our initial HPLC separation of our decomplexing bottom-up venom analysis. Chromatographic peak 
extraction of all individuals resulted in 119 consensus extracted ion chromatograms (XIC) or so-called 
ion features. The alignment of XICs by retention time and mass enabled the comparison of samples 
between individuals, and a comparison with the mass profile of the pooled venom sample for a protein 
level annotation. An overview of all resulting features, including annotations, is shown in 
supplemental table 1. The binary distribution of ion features showed that individual venoms contained 
between 62 and 107 features, with a slightly higher average feature number in juveniles vs. adults. 
Comparing the total ion currents (TIC) of the LC-MS runs, the individual with the lowest feature 
number also had the lowest overall signal. Hence it is likely that the lower number of features in this 
individual was due to lower overall signal intensity and therefore might not be biologically 
representative. For further statistical evaluation we normalized feature abundance to TIC. Matching 
the features to the pooled bottom-up venomics results yielded an annotation rate of between 83.4% 
and 93.5% of the features (based on XIC peak area). As anticipated, the annotation rate is slightly 
lower than the relative annotation of the pooled sample (96.0%; based on the UV214 peak area).  
A comparison of the resulting protein family venom compositions is shown in figure 4 and 
supplemental table 2. The highest variance was observed for svSP, CTL and LAAO toxin families 
(Figure 5A). Taking the age of the individuals into account, the abundance of svSPs was generally 
higher in the adult individuals than in the juveniles (average of 21.7% vs. 5.5 %), but no significant 
difference between male and female individuals, or between different geographic regions was 
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observed. The svSPs play a significant role in mammalian envenomation by affecting the hemostatic 
system through perturbing blood coagulation, typically via the inducement of fibrinogenolytic effects 
[79,80]. Taking this into account, a possible explanation could be that the lower svSP concentration 
observed in juveniles could be the result of differences in diet, as young animals typically prey on 
insects, before switching to feed upon small mammals and lizards as they become adults [81–83]. 
Despite observed variations in abundance, no significant differences were found between the 
individual groups for the CTL and LAAO toxin families (Figure 5A). However, there was evidence 
that svSP concentration is correlated to levels of LAAO, as the three individuals with the lowest svSP 
abundance showed the highest content of LAAO (Figure 5A). Whether this is a true biological effect 
or perhaps is the result of differences in ion suppression of the co-eluting compounds requires further 
investigation with large sample sizes. While we also observed variation between the PLA2 levels 
identified in the different venoms, which ranged from 6.5-25.1%, in all cases these abundances 
remained considerably lower than those previously reported by Kovalchuk et al. (41%) [52].  
In order to investigate the intra-species differences by multivariate statistics we performed a principal 
coordinate analysis (PCoA) using the Bray-Curtis dissimilarity metric. The PCoA plots of protein-
level and proteoform-level data are shown in figure 5. Clustering between adult and juvenile 
individuals in protein-family level PCoA space was not found to be significant (Figure 5B, ADONIS: 
r2=0.32, p=0.27). In addition, and as anticipated from the univariate statistics, no separation based on 
gender or geographical region could be observed. Since a possible explanation for not resolving 
phenotype differences could be the reduction of variables through the binning of proteoforms, we next 
used proteoform abundance as the input matrix for PCoA. The outcomes of this second analysis 
revealed a weak grouping between both juvenile and adults, as well as between male and female 
snakes (Figure 5C, ADONIS: r2=0.33, p=0.07). To investigating the toxin variants underpinning 
these separations, we used univariate comparisons of the two groups and plotted the fold change of 
toxin abundance (log2) vs. the statistical significance (-log10 p-value, t-test) shown in supplemental 
figure 2. Aside from the aforementioned differences in svSP toxins, the most significant (p-value < 
0.05, log2 fold change >2 or <-2) differences observed between juvenile and adult individuals was the 
higher abundance of small proteins (with masses 7707.26 Da, 5565.02 Da and 5693.10 Da) in the 
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juvenile group, all of which were unidentified in our proteomic analyses. In addition, we observed 
several smaller peptides (with masses 589.27 Da, 1244.56 Da, and 575.26 Da), as well as a putative 
PLA2 (13667.91 Da), that were more abundant in venom of the juveniles. Contrastingly, a putative 
PLA2 (13683.86 Da) was of lower abundance in the juvenile group. While we observed fewer 
significant changes between the venom toxins of the male and female individuals, the observed 
masses of the differential features indicated that some of those differential toxins belong to different 
protein families than those involved in differentiating between juvenile and adult snakes. Two toxins 
with the masses 22829.66 Da and 24641.23 Da were of higher abundant in male individuals, and 
could be putatively annotated as hetero-dimeric CTLs, while a third toxin (13549.87 Da, putative 
PLA2) was also of higher abundance in the males.  
 
4. Concluding remarks 
Herein we described comprehensive analyses of the venom composition of Vipera kaznakovi by a 
combination of venom gland transcriptomics and decomplexing bottom-up and top-down venom 
proteomics. Our findings revealed the presence of 15 toxin families, of which the most abundant 
toxins were svMPs (37.7%), followed by PLA2s (19.0%), svSPs (9.5%), CTLs (6.9%) and CRISP 
(5.0%). Intact mass profiling enabled the rapid comparison of venom sourced from multiple 
individuals. This population venomics approach enabled higher sensitivity of direct intact protein 
analysis by LC-MS, in comparison to decomplexing bottom-up venomics, and thus enabled us to 
work with multiple venom samples of low quantity (< 0.5 mg venom). This approach also permitted 
us to capture the snakes, perform venom extractions, and then immediately release the animals back 
into the field. Our findings revealed intraspecies venom variation in Vipera kaznakovi, including both 
ontogenetic differences between juvenile and adult snakes, and to a lesser extent, sexual differences 
between adult males and females. The highest significant difference in venom proteome composition 
was observed between the adult and juvenile group, with svSP toxins found to exhibit the greatest 
variance. However, individuals in all groups showed a generally high relative variance of CTL and 
LAAO concentrations. svMPs on the other hand seemed to be constantly the most abundant venom 
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component in all V. kaznakovi individuals analyzed in our study. However, as the statistical power 
with a relatively small subject size (n=9) is limited, we acknowledge that extending this study to a 
larger sample cohort, ideally covering all geographical regions (from Northeastern Turkey to Georgia 
and Russia) of the V. kaznakovi distribution zone, would be revealing. In conclusion, the top-down 
venom profiling approach that we applied herein appears to be well suited for extensive venom 
analysis at the population level, and will hopefully enable venom researchers to expand their 
experimental toolbox towards robust comparisons of intraspecies venom variation, and move beyond 
the characterization of pooled venoms. 
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Table 1. Venom Protein Identifications from Vipera kaznakovi. The table shows all protein identification of HPLC fractions (Fig. 3) by LC-MS and LC-MS/MS analysis from pooled venom. Peak numbering 
corresponds to the UV and MS chromatograms. Sequence tags were obtained by analysis of tryptic peptides by MS/MS de novo sequencing and/or peptide spectrum matching. Molecular weights of intact proteins 
were determined by SDS-PAGE and intact mass profiling (LC-MS). 
Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
1 20.1 
  
78423 
         
     
443.2 
   
pEQW tripeptide SVMPi - - svMP-i 
2 27.4 
  
3701 
         
     
432.2 
    
unknown - - Peptide 
3 28.2 
  
1928 
         
     
3390.6 
    
unknown 
  
Peptide 
4 30.3 
  
11784 
         
     
3942.8 
   
- unknown - - - 
     
860.3 
   
EPGEEDW Bradykinin‐potentiating peptide - BAN04688.1 BPP 
     
822.4 
   
pEKWPGPK Bradykinin‐potentiating peptide - BAN04688.1 BPP 
5 32.6 
  
1075 
         
     
3118.5 
   
- unknown - - Peptide 
     
680.3 
   
- unknown - - Peptide 
6 35.7 
  
3117 
         
     
3665.7 
   
- unknown - - Peptide 
7 36.8 
  
2039 
         
     
13848.7 
   
- unknown - - unknown 
8 41.2 
  
18410 
         
     
1101.6 
   
K/QPGPVSV unkown - - Peptide 
9 49.7 
  
2706 
    
- unknown - - unkown 
     
7228.2 
   
- unknown - - unkown 
     
6680.9 
        
10 50.4 
  
6454 
         
  
10A 35% 
  
14 PFXEVYQR 
T0203_R_0.03
14_L_1049 
PFXEVYQR Nerve groth factor 2.2E-02 
P83942.1 
VEGF 
       
HTVDXQXM*R HTVDXQXMR Nerve groth factor 5.1E-02 
 
       
ETXVPXXQEYPDEXSDXFRPSCVAVXR - - - - 
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Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
  
10B 65% 
  
15 AAAXCFGENVNTYDKK F8QN51.1 AAAXCAFGENVNTYDKK acidic phospholipase A2 3.0E-08 
F8QN51.1 
PLA2 
       
pCCFVHDCCYGR 
T1290_R_0.05
75_L_419 
NXFQFGK acidic phospholipase A2 
1.1E+0
0  
       
M*DTYSYSFXNGDXVCGDDPCXR MFCAGYXEGGK cationic trypsin-3-like 4.0E-05 XP_015670852.1 
 
       
SAYGCYCGWGGQGRPQDPTDR - - - - 
 
11, 
12 
61.2 
61.6 
11,12 100% 456 
         
    
62431 
13557.7; 
13540.8; 
13523.7 
15 AAAXCFGENVN*TYDKK F8QN51.1 AAAXCAFGENVNTYDKK acidic phospholipase A2 3.0E-08 F8QN51.1 PLA2 
      
M*DTYSYSFXN*GDXVCDGDDDPCXR 
T1290_R_0.05
75_L_419 
- - - - 
 
      
SAYGCYCGWGGQGRPQDPTDR - - - - 
 
      
SAXXSYSAYGCYCGWGGQGRPQDPTDR - - - - 
 
13 64.4 
  
1798 
        
unknown 
     
13541.8 
        
14 69.7 
  
962 
        
unknown 
     
24671.3 
        
15 70.5 
  
45974 
         
  
15A 71% 
 
24655.5 25 Q*GCNNNYXK 
B7FDI1.1 
QGCNNNYXK cyteine-rich venom protein 3.0E-03 B7FDI1.1 CRISP 
       
KPEXQN*EXXDXHNSXRR KPEXQNEXXDXHNSXR cyteine-rich venom protein 3.0E-05 XP_015678374.1 
 
       
NVDFDSESPR WTAXXHEWHGEEK cyteine-rich venom protein 4.0E-07 B7FDI1.1 
 
       
M*EWYPEAAANAER SVDFDSESPR cyteine-rich venom protein 2.0E-05 P86537.1 
 
       
SVNPTASNM*XK - - - - 
 
       
VDFDSESPR - - - - 
 
       
DFVYGQGASPANAVVGHYTQXVWYK - - - - 
 
              
  
15B 29% 
 
13691.8 13 HXSQFGDMXNK 
Q910A1 
HXSQFGDMXNK ammodytin  I1(A) variant 6.0E-04 CAE47141.1 PLA2 
       
pCCFVHDCCYGR - - - - 
 
       
VAAXCFGENM*NTYDQKK VAAXCAFGENMNTYDQK ammodytin  I1(A) variant 3.0E-09 CAE47176.1 
 
16, 
17 
73.3 
74.4   
56120 
         
  
17A 27% 
 
51761 50 FXTNFKPDCTXXRPSR 
T0053_R_0.07
34_L_1810 
VPXVGVEFWXNR snake venom metalloproteinase III 5.0E-04 ADW54336.1 svMP 
       
SECDXPEYCTGK 
 
XVXVVDHSMVEK snake venom metalloproteinase 9.0E-05 ADI47673.1 
 
       
XGQDXYYCR 
 
- - - - 
 
       
KEN*DVPXPCAPEDVK 
 
- - - - 
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Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
  
16, 17B 73% 
 
13675.9 14 HXSQFGDMXNK 
Q910A1 
HXSQFGDMXNK ammodytin  I1(A) variant 6.0E-04 CAE47141.1 PLA2 
       
pCCFVHDCCYGR - - - - 
 
       
VAAXCFGEN*M*NTYDQKK VAAXCAFGENMNTYDQK ammodytin  I1(A) variant 3.0E-09 CAE47176.1 
 
       
YMLYSIFDCK - - - - 
 
18 80.6 
  
90949 
         
  
18A 18% 
 
N.D. 65 XVXVVDHSM*VTK 
T0033_R_0.05
99_L_2024 
XVXVVDHSMVTK 
snake venom metalloproteinase 
group III 
1.0E-04 CAJ01689.1 svMP 
       
YN*SDXTVXR YNSDXTVXR snake venom metalloproteinase 2.9E-01 ADI47687.1 
 
       
VPXVGVEXWDHR VPXVGVEXWDHR snake venom metalloproteinase 6.5E-02 ADI47590.1 
 
       
pQXVATSEQQR - - - - 
 
       
VNXXNEM*YXPXNXR - - - - 
 
       
KRHDNAQXXTTXDFDGSVXGK - - - - 
 
       
HSVAXVEDYSPXDR - - - - 
 
       
FXTNDKPDCTXXRPSR - - - - 
 
       
KGESYFYCR KGESYFYCR snake venom metalloproteinase 9.0E-05 ADI47619.1 
 
       
KENDVPXPCAPEDXK - - - - 
 
              
  
18B 8% 
 
51600 50 FXTNFKPDCTXXRPSR 
T0053_R_0.07
34_L_1810 
VPXVGVEFWXNR 
snake venom metalloproteinase 
group III 
5.0E-04 ADW54336.1 svMP 
       
SECDXPEYCTGK XVXVVDHSMVEK snake venom metalloproteinase 9.0E-05 ADI47673.1 
 
       
XGQDXYYCR - - - - 
 
       
KEN*DVPXPCAPEDVK - - - - 
 
              
  
18C 53% 
 
30133 35 VXGGDECNXNEHPFXVAXHTAR T1355_R_0.00
5_L_400 
VXGGDECANXNEHPFXAFVTSDR 
snake venom serine proteinase 
nikobin 
2.0E-12 E5AJX2.1 svSP 
       
FYCAGTLXNQEWVXTAAR XMGWGTXSSTK snake venom serine proteinase 3.0E-05 ART88740.1 
 
       
VVCAGXWQGGK 
E5AJX2 
VVCAGXWQGGK 
snake venom serine proteinase 
nikobin 
1.0E-04 E5AJX2.1 
 
       
C*AGTXXNQEWVXTAAHCNGK XMGWGTXTTTK snake venom serine proteinase 6.0E-04 ADE45141.1 
 
       
XXPDVPHCANXEXXK - - - - 
 
       
VHPEXPAK - - - - 
 
              
  
18D 20% 
 
17249 14 KTWEDAEKFCTEQAR 
T0841_R_0.07
82_L_536 
WTEDAENFCQK C-type lectin snaclec-1 1.0E-04 AMB36338.1 CTL 
       
SPEEVDFM*XK SPEEVDFMXK C-type lectin-like protein 2B 1.1E-02 AJO70722.1 
 
       
ADXVWXGXR HXATXEWXGK C-type lectin snaclec A16 1.8E-01 B4XSZ1.1 
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Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
19, 
20 
85.3 
86.6   
32261 
         
  
19/20 100% 
 
49299 50 XGQDXYYCR 
T0053_R_0.07
34_L_1810 
XGQDXYYCR 
zinc metalloproteinase disintegrin-
like 
1.4E-01 Q0NZX8.1 svMP 
       
HDNAQXXTAXDFDGPTXGXAHMSSMCQSK XVXVVDHSMVEK snake venom metalloproteinase 9.0E-05 ADI47673.1 
 
       
SVAFVEDYSPXDHMVASTMAHEMGHNXGMR VPXVGVEFWXNR 
snake venom metalloproteinase 
group III 
5.0E-04 ADW54336.1 
 
       
FXTNFKPDCTXXRPSR pEXVATSEQQSYYDRFR snake venom metalloproteinase 2.0E-10 ADI47633.1 
 
       
SWVQCESGECCEQCR - - - - 
 
       
SECDXPEYCTGK - - - - 
 
       
KEN*DVPXPCAPEDVK - - - - 
 
       
XYCEXVPN - - - - 
 
21 91.3 
  
52573 
         
  
21 100% 
 
57374 60 VGEVNKDPGXXK 
T0018_R_0.06
57_L_2450 
VGEVNKDPGXXK L-amino acid oxidase 7.0E-04 BAN82140.1 LAAO 
       
VTVXEASER VTVXEASER L-amino acid oxidase 5.0E-02 Q6WP39.1 
 
       
NVEEGWYANXGPM*RXPEK - - - - 
 
       
HXVVVGAGM*SGXSAAYVXAGAGHK - - - - 
 
       
SAGQXYEESXKK - - - - 
 
       
TFCYPSMXQK - - - - 
 
              
     
N.D. 50 YNSDXTVXR 
T0033_R_0.05
99_L_2024 
YNSDXTVXR snake venom metalloproteinase 2.9E-01 ADI47687.1 svMP 
       
XVXVVDHSMVTK - - - - 
 
       
VPXVGVEXWDHR - - - - 
 
       
HSVAXVEDYSPXDR - - - - 
 
       
KENDVPXPCAPEDXK - - - - 
 
22 95.5 
  
15611 
         
  
22A 58% 
 
N.D. 65 XVXVVDHSM*FTK 
T0039_R_0.01
84_L_1944 
XVXVVDHSMFTK 
zinc metalloproteinase disintegrin-
like 
7.0E-04 Q9IAX6.1 svMP 
       
XYEM*VNTXNVVFR XYEMVNTXNVVFR 
snake venom metalloproteinase 
group III 
1.0E-06 AMB36352.1 
 
       
VAXVYXEM*WTNR KXVYXEMWTNR 
snake venom metalloproteinase 
group III 
4.0E-04 AMB36352.1 
 
       
XHSWVECESGECCDQCR - - - - 
 
       
AXFGANAAVGQDACFDWNKK - - - - 
 
       
GTDDFYCR - - - - 
 
     
8415.9 
 
XFCEIVPNTCK - - - - 
 
       
XHSWVECESGECCEQCR 
T0033_R_0.05
99_L_2024 
- - - - 
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Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
  
22B 26% 
 
48846 50 YNSDXTVXR 
T0033_R_0.05
99_L_2024 
YNSDXTVXR snake venom metalloproteinase 
2.4E+0
0 
CAJ01688.1 svMP 
       
HSVAXVEDYSPXDR STHSPDDPDYGMVDXGTK 
zinc metalloproteinase disintegrin-
like 
2.0E-11 P0DJE2.3 
 
       
XYEM*VNTXNVVFR 
T0039_R_0.01
84_L_1944 
XXCVKPPTGNXXSCK snake venom metalloproteinase 3.2E-01 AHB62069.1 
 
              
  
22C 16% 
 
19174 20 TSADYVWXGXWNQR T0790_R_0.04
56_L_550 
TSADYVWXGXWNQR C-type lectin-like protein 2B 4.0E-09 AJO70726.1 CTL 
       
WTDGSSVXYK TTDNQWXR C-type lectin snaclec 7 2.0E-02 Q4PRC6.1 
 
23 96.4 
  
53265 
         
  
23 
  
48161; 
59182 
65 - - VPXPCANQVXK snake venom metalloproteinase 
7.3E+0
0 
ADI47650.1 svMP 
24 104.6 
  
38719 
         
  
24A 80% 
 
57509 65 VPXVGVEXWDHR 
T0033_R_0.05
99_L_2024 
VPXVGVEXWDHR snake venom metalloproteinase 6.5E-02 ADI47590.1 svMP 
       
pQXVATSEQQR - - - - 
 
       
YNSDXTVXR - - - - 
 
       
VNXXNEMYXPXNXR - - - - 
 
       
SDPDYAM*VDXGTK 
T0039_R_0.01
84_L_1944 
SDPDYAMVDXGTK snake venom metalloproteinase 7.0E-05 ADI47642.1 
 
       
SVGXXQDYCK - - - - 
 
       
CFNYNXQGTENFHCGMENGR CFNYNXQGTENFHCGMENGR snake venom metalloproteinase 5.0E-14 AHB62069.1 
 
              
  
24B 6% 
 
30133 30 XPSSPPSVGSVCR T0596_R_0.00
34_L_647 
XPSSPPSVGSVCR 
snake venom serine proteinase 
isoform 7 
3.0E-06 ABG26973.1 svSP 
       
FYCAGYQNNDWDKDXMXXK FYCAAGYQNNDWDKDXMXXK snake venom serine proteinase SP-3 8.0E-06 AMB36344.1 
 
              
  
24C 14% 
 
17061 15 SPEEVDFM*XK 
T0841_R_0.07
82_L_536 
SPEEVDFMXK C-type lectin-like protein 2B 1.1E-02 AJO70722.1 CTL 
       
KTWEDAEKFCTEQAR KTWEDAEKFCTEQAR C-type lectin snaclec 7 4.0E-11 B4XT06.1 
 
       
GGHXXSXK HXATXEWXGK C-type lectin snaclec A16 1.8E-01 B4XSZ1.1 
 
       
ADXVWXGXR - - - - 
 
       
AWSDEPNCFAAK T0512_R_0.23
94_L_699 
- - - - 
 
       
TTDNQWXRR - - - - 
 
25 108.7 
  
69780 
         
  
25A 57% 
 
57516 60 HXVVVGAGM*SGXSAAYVXAGAGHK 
T0018_R_0.06
57_L_2450 
- - - - LAAO 
       
VTVXEASER - - - - 
 
       
NVEEGWYANXGPMR - - - - 
 
       
KFGXQXNEFVQETDNGWYFXK - - - - 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PTE
D M
AN
US
CR
IPT
 
 
Peak RT 
SDS-
PAGE 
Band 
Area% 
SDS-
PAGE 
Area  
(214 
nm) 
Mass [Da]  
(ESI-MS) 
Mass 
[kDa]  
(SDS-
PAGE) 
Sequence [PSM] Prot-ID Sequence (de novo) Identity (blast) e-value 
Accession  
Number 
Protein 
Family 
  
25A 57% 
 
57516 60 VGEVNKDPGXXK 
T0018_R_0.06
57_L_2450 
- - - - LAAO 
  
     SAGQXYEESXK - - - - 
 
       
XFFAGEYTANAHGWXDSTXK - - - - 
 
       
VPXVGVEXWDHR 
T0033_R_0.05
99_L_2024 
VPXVGVEXWDHR snake venom metalloproteinase 6.5E-02 ADI47590.1 svMP 
       
pQXVATSEQQR - - - - 
 
       
XVXVVDHSMVTK NPCQXYYTPR snake venom metalloproteinase 6.0E-05 AGL45259.1 
 
       
YNSDXTVXR YNSDXTVXR snake venom metalloproteinase 2.9E-01 ADI47687.1 
 
       
VNXXNEM*YXPXNXR - - - - 
 
       
HDNAQXXTTXDFDGSVXGK - - - - 
 
       
HSVAXVEDYSPXDR - - - - 
 
       
KENDVPXPCAPEDXK - - - - 
 
              
  
25B 16% 
 
30131 30 - - XPSSPPSVGSVCR 
snake venom serine proteinase 
isoform 7 
3.0E-06 ABG26973.1 svSP 
              
  
25C 27% 
 
N.D. 15 - - - - - - CTL 
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Figure 1. The geographical distribution and sampling localities of Vipera kaznakovi. The distribution area of the 
Caucasus viper (Vipera kaznakovi, genus Viperidae) is highlighted on the map in the lower right corner and adapted from 
Geniez et al. [84]. The locations and sex/age of the collected individuals are marked on the map (orange – adult male, red – 
adult female, blue - juvenile). 
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Figure 2. The relative expression levels of toxin families identified in the Vipera kaznakovi venom gland 
transcriptome. A The left pie chart shows the relative expression levels of the major toxin families, each of which accounts 
for greater than 4% of all toxins encoded in the venom gland. The right pie chart shows the relative expression levels of the  
remaining toxin families, which in combination account for 12.11% of all toxins encoded in the venom gland (“others”). 
Percentage values on both charts reflect the expression level of each toxin family as a percentage of the total expression of 
all identified toxin families. B The relative expression levels of individual contigs encoded by the most abundantly expressed 
toxin families (CTL, svMP, svSP and PLA2). Key: svMP – snake venom metalloproteinase; CTL – C-type lectin; svSP – 
snake venom serine protease; PLA2 – phospholipase A2; CRISP – cysteine-rich secretory protein; LAAO – L-amino acid 
oxidase; kunitz – kunitz-type inhibitors; VEGF – vascular endothelial growth factor; PLA2-i – PLA2 inhibitors, SVMP-i – 
SVMP inhibitors PLB – phospholipase B; NGF – nerve growth factor; RLAP – renin-like aspartic proteases; 5’ Nuc – 5’ 
nucleotidase. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
 
 
Figure 3. Bottom-up snake venomics of Vipera kaznakovi. A Venom separation of V. kaznakovi was performed by a 
Supelco Discovery BIO wide Pore C18-3 RP-HPLC column and UV absorbance measured at λ = 214 nm. B Total ion 
current (TIC) profile of crude V. kaznakovi venom. The peak nomenclature is based on the chromatogram fractions. C The 
RP-HPLC fractions (indicated above the lane) of the V. kaznakovi venom was analysed by SDS-PAGE under reducing 
conditions (Coomassie staining). Alphabetically marked bands per line were excised for subsequent tryptic in-gel digestion. 
D The relative occurrence of different toxin families of V. kaznakovi are represented by the pie chart. Identification of snake 
venom metalloproteinase (svMP, red), phospholipases A2 (PLA2, blue), snake venom serine proteinase (svSP, green), C-type 
lectin like proteins (CTL, purple), cysteine rich secretory proteins (CRISP, light blue), bradykinin-potentiating peptides 
(BPP, light brown), vascular endothelial growth factors (VEGF-F, red), unknown proteins (n/a, black) and peptides (grey). 
The de novo identified peptides are listed in supplemental table 1. 
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Figure 4. Intact molecular mass profiles of venom from several individuals of V. kaznakovi. The total ion counts (TIC) 
of native, crude venoms from several V. kaznakovi individuals were measured by HPLC-ESI-MS. The relative abundance 
was set to 100% for the highest peak. The peak nomenclature is based on the chromatogram fractions and is shown in figure 
3A. The identified molecular masses of intact proteins and peptides are listed in supplemental table 2. The intact molecular 
mass profiling includes three juveniles of unknown sex (blue circle), and two female (red Venus symbol) and four male 
(orange Mars symbol) adult individuals. 
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Figure 5. Principal Component Analysis (PCoA) and relative compositions of the individual V. kaznakovi venoms. A 
The proteome overview includes three juveniles of unknown sex (blue circle), and two female (red Venus symbol) and four 
male (orange Mars symbol) adult individuals. B and C The compositional similarity of venom is displayed through Bray-
Curtis-Faith distance in PCoA space. Toxin similarity is visualized at the protein family level (B) and proteoform level (C).  
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Biological Significance 
Population level and ontogenetic venom variation (e.g. diet, habitat, sex or age) can result in a loss of 
antivenom efficacy against snakebites from wide ranging snake populations. The current state of the 
art for the analysis of snake venoms are de-complexing bottom-up proteomics approaches. While 
useful, these have the significant drawback of being time-consuming and following costly protocols, 
and consequently are often applied to pooled venom samples. To overcome these shortcomings and to 
enable rapid and detailed profiling of large numbers of individual venom samples, we integrated an 
intact protein analysis workflow into a transcriptomics-guided bottom-up approach. The application 
of this workflow to snake individuals of a local population of V. kaznakovi revealed intraspecies 
variations in venom composition, which are primarily explained by the age of the animals, and 
highlighted svSP abundance to be one of the molecular drivers for the compositional differences 
observed.  
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